Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 1686 results found. Search for [ Sun Pharma ]

Results 1660 to 1680 of 1686
Suman Layak
June 22, 2010
Businesses — both domestic and global — are forking out big bucks for Indian assets. Could this be the silly season for valuations?


E. Kumar Sharma
June 9, 2010
Piramal's domestic formulations business becomes the latest—and most expensive—acquisition of an Indian drug business by a global pharma major. As the stakes get higher, who's next?


E. Kumar Sharma
November 15, 2009
While MNCs are invading India in a desperate quest for new markets, Indian pharma firms are struggling to expand and rise up the value chain in a tough, competitive environment.


Dipen Sheth
October 28, 2009
Dipen Sheth tries to guess which companies and sectors will make it to the Top 20 slots 10 years from now.


Virendra Verma
September 3, 2009
India’s most valuable pharma firm has stumbled, as a US subsidiary gets on the wrong side of the FDA and a handful of exclusive arrangements come to an end. Can founder Dilip Shanghvi get Sun Pharma back on the road to supernormal profits?


E. Kumar Sharma
August 19, 2009
By refocussing its strategies, Natco Pharma has pulled back from the brink of bankruptcy to power ahead in cancer drugs. Now it is looking for niche areas globally. Can it scale up and take on global competition?


Rachna M. Koppikar
August 19, 2009
As mergers & acquisitions become a way of life at India Inc., CEOs are leaning heavily on their teams of dealmakers who are not too far away from the corner room.


Virendra Verma
March 5, 2009
Sun Pharma rises out of the gloom thanks to its distinctive four-pronged game plan.


Virendra Verma
March 5, 2009
They’ve been posting robust double-digit growth for two quarters now even as their peers struggle to come to terms with the downturn. Virendra Verma finds out what makes these companies tick when business dips?


www.businesstoday.in
March 5, 2009
This is Business Today’s Third Annual Listing of hottest start-ups and, pretty much like the two previous lists in 2007 and 2008, this listing is also completely subjective.


www.businesstoday.in
February 5, 2009
Their collective size is equivalent to that of a mid-level Indian corporation. Yet, the big four auditing firms— EY, PwC, KPMG, Deloitte Tuche Thmatsu— have a crucial role in policing the bookkeepers of India Inc. Big cheese Vs small frySome don’t like it bigThe problem withinThe bloodhounds of bookkeepingInside the secret world of auditing


T.V. Mahalingam
November 13, 2008
Export-dependent IT, biotech and pharma firms have their backs to the wall with the rupee gyrating and their overseas markets in turmoil. When will the markets look up again? T.V. Mahalingam goes into the details.


Suman Layak
November 13, 2008
It has been a great 12 months for Sun Pharmaceutical Industries and an even better first half for 2008-09. The company has reported a 76 per cent year-on-year growth in sales and a 134 per cent growth in net profits for the quarter ended on September 30, 2008. Suman Layak says that it stays ahead of the pack with a clear focus on consistency, profitability and some clever moves in its main market, the US.


www.businesstoday.in
September 4, 2008
Sun pharma’s hostile bid to take over Israeli drug major Taro Pharma received a fillip last fortnight. An Israeli court ruled in favour of Sun and against the motion of Taro to conduct a special tender offer.


www.businesstoday.in
August 6, 2008
After Daiichi Sankyo’s purchase of Ranbaxy Labs, Teva Pharma, the world’s largest generics company, acquired Barr Pharma, the US’ fourth largest generics firm. There are two questions on pharma analysts’ lips these days: Who’s next? Are Indian generics players targets for pharma MNCs?


Suman Layak
July 10, 2008
An erosion in market cap makes cross-border buyouts more difficult.


E Kumar Sharma
June 25, 2008
A healthy dose of pharma stocks in your portfolio can be a good defensive strategy in this volatile market.


T.V. Mahalingam
June 10, 2008
A year ago in late May 2007, Mumbai-headquartered Sun Pharma, together with its subsidiaries, had signed 'definitive agreements' to acquire Taro Pharmaceutical Industries, a multinational manufacturer of generic pharmaceuticals. A year later, the transaction is in tatters and both parties are washing dirty linen in public. Why? T.V. Mahalingam finds out the reasons.


Manu Kaushik
June 9, 2008
The market is going through a rough phase as it navigates cross-currents. What should investors do?


www.businesstoday.in
May 28, 2008
Companies with revenues between Rs 1,000 crore and Rs 2,000 crore that grew the fastest in 2007.


PAGES 84 OF 85  8182838485